Search Results

Ozempic keeps wowing: trial data show benefits for kidney disease.

• Authors : Fairbank R

Subjects: Clinical Trials as Topic* ; Kidney Diseases*/Kidney Diseases*/Kidney Diseases*/drug therapy ; Kidney Diseases*/Kidney Diseases*/Kidney Diseases*/etiology

• Source: Nature [Nature] 2024 Jun; Vol. 630 (8015), pp. 16-17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium:

Record details

Beyond Ozempic: brand-new obesity drugs will be cheaper and more effective.

• Authors : Sidik S

Subjects: Drug Costs* ; Drug Development*/Drug Development*/Drug Development*/economics ; Drug Development*/Drug Development*/Drug Development*/trends

• Source: Nature [Nature] 2023 Jul; Vol. 619 (7968), pp. 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium:

Record details

Weight-loss-drug pioneer: this biochemist finally gained recognition for her work.

• Authors : Dolgin E

Subjects: Anti-Obesity Agents* ; Research Personnel*; Humans

• Source: Nature [Nature] 2023 Dec; Vol. 624 (7992), pp. 506.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium:

Record details

Exon duplication and divergence in the human preproglucagon gene

• Authors : Bell, Graeme I.; Sanchez-Pescador, Ray; Laybourn, Paul J.

• Source: Nature; July 1983, Vol. 304 Issue: 5924 p368-371, 4p

Record details

Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome.

• Authors : Perry, Rachel J.; Peng, Liang; Barry, Natasha A.

• Source: Nature; 6/9/2016, Vol. 534 Issue 7606, p213-217, 5p, 1 Diagram, 15 Graphs

Record details

New drug targets for type 2 diabetes and the metabolic syndrome.

• Authors : Moller, David E.

Subjects: TYPE 2 diabetes treatment; INSULIN resistance; DRUG target

• Source: Nature; 12/13/2001, Vol. 414 Issue 6865, p821, 7p, 4 Diagrams, 2 Charts

Record details

Protein growth area.

Subjects: BIOCHEMISTRY; BIOCOLOR (Company); GENEMACHINES (Company)

• Source: Nature; 6/21/2001, Vol. 411 Issue 6840, p975, 2p, 3 Color Photographs

Record details

Melanocortin receptors in leptin effects.

• Authors : Seeley RJ; Yagaloff KA; Fisher SL

Subjects: Eating/Eating/Eating/*drug effects ; Proteins/Proteins/Proteins/*pharmacology ; Receptors, Corticotropin/Receptors, Corticotropin/Receptors, Corticotropin/*metabolism

• Source: Nature [Nature] 1997 Nov 27; Vol. 390 (6658), pp. 349.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium:

Record details

Glucagon-like peptide-1 and satiety.

• Authors : van Dijk G; Thiele TE; Seeley RJ

Subjects: Neuropeptides/Neuropeptides/Neuropeptides/*physiology ; Peptide Fragments/Peptide Fragments/Peptide Fragments/*physiology ; Satiety Response/Satiety Response/Satiety Response/*physiology

• Source: Nature [Nature] 1997 Jan 16; Vol. 385 (6613), pp. 214.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium:

Record details

A role for glucagon-like peptide-1 in the central regulation of feeding.

• Authors : Turton MD; Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.; O'Shea D

Subjects: Cerebral Ventricles/Cerebral Ventricles/Cerebral Ventricles/*physiology ; Eating/Eating/Eating/*physiology ; Peptide Fragments/Peptide Fragments/Peptide Fragments/*physiology

• Source: Nature [Nature] 1996 Jan 04; Vol. 379 (6560), pp. 69-72.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium:

Record details